XML 50 R36.htm IDEA: XBRL DOCUMENT v3.20.2
11. STOCKHOLDERS' EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Tables)
12 Months Ended
May 31, 2020
Equity [Abstract]  
Compensation costs related to the Company's stock-based compensation

    The following table summarizes the stock-based compensation expense for the fiscal years ended May 31, 2020, 2019 and 2018 (in thousands, except per share data):

 

   Year Ended May 31,
   2020  2019  2018
Stock-based compensation in the form of stock options, RSUs, and ESPP purchase rights, included in:           
          
Cost of sales  $80   $104   $148 
Selling, general and administrative   631    545    592 
Research and development   199    256    256 
                
Net effect on net (loss) income  $910   $905   $996 
                
Effect on net (loss) income per share:               
  Basic  $0.04   $0.04   $0.05 
  Diluted  $0.04   $0.04   $0.04 

 

Fair value assumptions for Option Valuation Model

    The fair values of the Company’s stock options granted to employees in fiscal 2020, 2019 and 2018 were estimated using the following weighted average assumptions in the Black-Scholes option valuation method:

 

   Year Ended May 31,
   2020  2019  2018
          
Expected term (in years)   5    5    4 
Volatility   0.72    0.72    0.77 
Risk-free interest rates   1.56%   2.83%   1.95%
Weighted-average grant date fair value  $0.95   $1.33   $2.07 

 

Fair value assumption of the ESPP Purchase Rights

    The fair value of our ESPP purchase rights for the fiscal 2020, 2019 and 2018 was estimated using the following weighted-average assumptions:

 

   Year End May 31,
   2020  2019  2018
          
Expected term (in years)   0.5 – 2.0    0.5 – 2.0    0.5 – 2.0 
Volatility   0.62 – 0.77    0.48 – 0.78    0.56 – 0.81 
Risk-free interest rates   0.14%–1.81%    2.33%–2.82%    1.92%–2.25% 
Weighted-average grant date fair value  $0.79   $1.14   $1.01 

 

Stock option and RSU transactions

    The following tables summarize the Company’s stock option and RSU transactions during fiscal 2020, 2019 and 2018 (in thousands):

 

   Available
   Shares
Balance, May 31, 2017   2,169 
      
Options granted   (338)
RSUs granted   (64)
RSUs cancelled   33 
Options terminated   16 
Options expired   (4)
      
Balance, May 31, 2018   1,812 
      
Options granted   (804)
RSUs cancelled   8 
Options terminated   195 
Options expired   (64)
      
Balance, May 31, 2019   1,147 
      
        Additional shares reserved   1,196 
Options granted   (738)
RSUs granted   (25)
Shares withheld for taxes and not issued   6 
Options terminated   457 
Options expired   (393)
      
Balance, May 31, 2020   1,650 

 

Stock option transactions

    The following table summarized the stock option transactions during fiscal 2020, 2019 and 2018 (in thousands, except per share data):

 

    Outstanding Options  
          Weighted        
    Number     Average     Aggregate  
    of     Exercise     Intrinsic  
    Shares     Price     Value  
Balances, May 31, 2017     3,074     $ 1.73     $ 8,763  
                         
Options granted     338     $ 3.56          
Options terminated     (16 )   $ 2.72          
Options exercised     (537 )   $ 1.17          
                         
Balances, May 31, 2018     2,859     $ 2.04     $ 1,987  
                         
Options granted     804     $ 2.19          
Options terminated      (195 )   $ 2.32          
Options exercised     (361 )   $ 0.85          
                         
Balances, May 31, 2019     3,107     $ 2.20     $ 283  
                         
Options granted     738     $ 1.61          
Options terminated     (457 )   $ 1.98          
Options exercised     (235 )   $ 1.22          
                         
Balances, May 31, 2020     3,153     $ 2.17     $ 102  
                         
Options fully vested and expected to vest at May 31, 2020     3,115     $ 2.17     $ 101  

 

Options outstanding

    The options outstanding and exercisable at May 31, 2020 were in the following exercise price ranges (in thousands, except per share data):

 

   Options Outstanding  Options Exercisable
   at May 31, 2020  at May 31, 2020

Range of Exercise
Prices

  Number Outstanding Shares  Weighted Average
Remaining Contractual Life
(Years)
  Weighted Average Exercise
Price
  Number Exercisable Shares  Weighted Average
Remaining Contractual Life
(Years)
  Weighted Average Exercise
Price
  Aggregate Intrinsic Value
1.22-$1.28    248    2.10   $1.26    176    0.19   $1.28      
1.64-$1.77    945    5.35   $1.66    487    4.66   $1.68      
2.03-$2.46    1,223    3.70   $2.21    858    3.03   $2.19      
2.63-$2.81    511    1.29   $2.70    510    1.28   $2.70      
3.46-$3.93    226    4.16   $3.84    172    4.18   $3.82      
                                       
1.22-$3.93    3,153    3.71   $2.17    2,203    2.85   $2.25   $67